FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2025704703> ?p ?o ?g. }

• W2025704703 endingPage "618" @default.
• W2025704703 startingPage "608" @default.
• W2025704703 abstract "Amiodarone was introduced as an antiarrhythmic compound in the early 1970s and was approved in the U.S. for the treatment of refractory ventricular arrhythmias in late 1984. Since that time the drug has become the most widely studied antiarrhythmic compound with expanding potential indications, including maintaining stability of sinus rhythm, secondary prevention in the survivors of myocardial infarction, and prolongation of survival in certain subsets of patients with congestive heart failure. Intravenous amiodarone was introduced in the U.S. in 1995 for the control of recurrent destabilizing ventricular tachycardia or ventricular fibrillation resistant to conventional therapy. The level of comfort in its use has risen considerably in the recent past. This has stemmed from the reasonably decisive evidence that class I agents increase mortality in patients with structural heart disease. In contrast, amiodarone either reduces mortality or its effect is neutral; this is consistent with its low to negligible proarrhyfhmic actions. The drug does not aggravate heart failure and it may even increase left ventricular ejection fraction and improve exercise capacity. Above all, it is becoming increasingly evident from wider experience and from controlled clinical trials that the side-effect profile of the drug is not as compelling an issue as it appeared to be when first used in much higher doses. Therefore, the overall objective of amiodarone therapy is to use the lowest dose that produces a defined therapeutic end point without causing serious side effects. Careful clinical surveillance in conjunction with monitoring of certain laboratory parameters and indices of efficacy at regular intervals permits the drug to be used effectively in a large number of patients who fail to respond to, or are intolerant of other antiarrhythmic compounds. Many experienced clinicians have begun to consider the use of amiodarone as first-line therapy in certain disorders of rhythm, especially in patients with severely compromised ventricular function." @default.
• W2025704703 created "2016-06-24" @default.
• W2025704703 creator A5037182975 @default.
• W2025704703 date "1997-07-01" @default.
• W2025704703 modified "2023-10-14" @default.
• W2025704703 title "Amiodarone: The expanding antiarrhythmic role and how to follow a patient on chronic therapy" @default.
• W2025704703 cites W1966051956 @default.
• W2025704703 cites W1970415212 @default.
• W2025704703 cites W1980240868 @default.
• W2025704703 cites W1982973712 @default.
• W2025704703 cites W1991821124 @default.
• W2025704703 cites W1991977300 @default.
• W2025704703 cites W1994640924 @default.
• W2025704703 cites W1995080987 @default.
• W2025704703 cites W1998016194 @default.
• W2025704703 cites W2010386758 @default.
• W2025704703 cites W2018699642 @default.
• W2025704703 cites W2021112825 @default.
• W2025704703 cites W2032863544 @default.
• W2025704703 cites W2034645031 @default.
• W2025704703 cites W2034907283 @default.
• W2025704703 cites W2067152768 @default.
• W2025704703 cites W2068641068 @default.
• W2025704703 cites W2070397684 @default.
• W2025704703 cites W2072298555 @default.
• W2025704703 cites W2073041630 @default.
• W2025704703 cites W2080764419 @default.
• W2025704703 cites W2096954801 @default.
• W2025704703 cites W2102870355 @default.
• W2025704703 cites W2109726742 @default.
• W2025704703 cites W2109740912 @default.
• W2025704703 cites W2110057127 @default.
• W2025704703 cites W2145213930 @default.
• W2025704703 cites W2152098901 @default.
• W2025704703 cites W2172282913 @default.
• W2025704703 cites W2332287011 @default.
• W2025704703 cites W4236770673 @default.
• W2025704703 cites W4237463984 @default.
• W2025704703 doi "https://doi.org/10.1002/clc.4960200706" @default.
• W2025704703 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6656071" @default.
• W2025704703 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9220176" @default.
• W2025704703 hasPublicationYear "1997" @default.
• W2025704703 type Work @default.
• W2025704703 sameAs 2025704703 @default.
• W2025704703 citedByCount "59" @default.
• W2025704703 countsByYear W20257047032012 @default.
• W2025704703 countsByYear W20257047032013 @default.
• W2025704703 countsByYear W20257047032014 @default.
• W2025704703 countsByYear W20257047032015 @default.
• W2025704703 countsByYear W20257047032018 @default.
• W2025704703 countsByYear W20257047032019 @default.
• W2025704703 crossrefType "journal-article" @default.
• W2025704703 hasAuthorship W2025704703A5037182975 @default.
• W2025704703 hasBestOaLocation W20257047031 @default.
• W2025704703 hasConcept C121332964 @default.
• W2025704703 hasConcept C126322002 @default.
• W2025704703 hasConcept C142424586 @default.
• W2025704703 hasConcept C164705383 @default.
• W2025704703 hasConcept C2775914520 @default.
• W2025704703 hasConcept C2776331378 @default.
• W2025704703 hasConcept C2778094803 @default.
• W2025704703 hasConcept C2778131192 @default.
• W2025704703 hasConcept C2778198053 @default.
• W2025704703 hasConcept C2779161974 @default.
• W2025704703 hasConcept C2780074459 @default.
• W2025704703 hasConcept C2781005686 @default.
• W2025704703 hasConcept C500558357 @default.
• W2025704703 hasConcept C71924100 @default.
• W2025704703 hasConcept C78085059 @default.
• W2025704703 hasConcept C87355193 @default.
• W2025704703 hasConceptScore W2025704703C121332964 @default.
• W2025704703 hasConceptScore W2025704703C126322002 @default.
• W2025704703 hasConceptScore W2025704703C142424586 @default.
• W2025704703 hasConceptScore W2025704703C164705383 @default.
• W2025704703 hasConceptScore W2025704703C2775914520 @default.
• W2025704703 hasConceptScore W2025704703C2776331378 @default.
• W2025704703 hasConceptScore W2025704703C2778094803 @default.
• W2025704703 hasConceptScore W2025704703C2778131192 @default.
• W2025704703 hasConceptScore W2025704703C2778198053 @default.
• W2025704703 hasConceptScore W2025704703C2779161974 @default.
• W2025704703 hasConceptScore W2025704703C2780074459 @default.
• W2025704703 hasConceptScore W2025704703C2781005686 @default.
• W2025704703 hasConceptScore W2025704703C500558357 @default.
• W2025704703 hasConceptScore W2025704703C71924100 @default.
• W2025704703 hasConceptScore W2025704703C78085059 @default.
• W2025704703 hasConceptScore W2025704703C87355193 @default.
• W2025704703 hasIssue "7" @default.
• W2025704703 hasLocation W20257047031 @default.
• W2025704703 hasLocation W20257047032 @default.
• W2025704703 hasLocation W20257047033 @default.
• W2025704703 hasLocation W20257047034 @default.
• W2025704703 hasOpenAccess W2025704703 @default.
• W2025704703 hasPrimaryLocation W20257047031 @default.
• W2025704703 hasRelatedWork W2036876924 @default.
• W2025704703 hasRelatedWork W2038313682 @default.
• W2025704703 hasRelatedWork W2049667380 @default.
• W2025704703 hasRelatedWork W2148343657 @default.
• W2025704703 hasRelatedWork W2156558544 @default.

• next